Skip to main content
Equibles
NTLA logo

NTLA · Intellia Therapeutics, Inc. · Short Interest

Track NTLA — free

Use NTLA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NTLA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.84 +0.26 (+2.25%) At close · Oct 20
Russell 2000 member Rebalance outlook locked
Market Cap
$1.62B
Shares
140.13M
Volume · Oct 20 3.42M Avg daily vol (3M) 4.33M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Pull short interest history through the short interest API or MCP →

NTLA Latest Reported Short Interest

FINRA reported 45,110,513 NTLA shares sold short as of the September 30, 2026 settlement date, a decrease of 1,571,096 shares. Days to cover was 9.47 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

NTLA Short Interest Forecast

Equibles' model estimates 45,474,660 shares sold short for the October 15, 2026 settlement, +0.8% versus the latest reported position, with a likely range of 41,576,620 to 49,522,524 shares. This model prediction uses FINRA data through October 15, 2026; FINRA's official release is expected October 26, 2026.

Model estimate

Expected Oct 15 short interest

as of Oct 15 Low confidence 50% chance it rises
45,474,660 +0.8% vs reported
Likely range 41,576,620 to 49,522,524 The latest estimate appears in the chart below. Official release expected Oct 26. Methodology
Short Squeeze Score
82/100
Short interest 32.2% of shares — P100 Days to cover 9.5 — P90 Price vs VWAP -1.5% — P65 Short-volume trend +6.6% — P76 Short interest change -3.4% — P38 Worst FTD 0.28% of shares — P91

Positioning score 82.0 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-09-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-10-21 05:21 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-10-30 Scheduled
    FINRA publishes Nov 10
    		 — — — —
    2026-10-15 Scheduled
    FINRA publishes Oct 26
    		 — — — —
    2026-09-30 45,110,513 46,681,609 -1,571,096 9.47
    2026-09-15 46,681,609 43,928,014 +2,753,595 14.10
    2026-08-31 43,928,014 44,880,339 -952,325 12.89
    2026-08-14 44,880,339 44,010,769 +869,570 13.15
    2026-07-31 44,010,769 45,776,294 -1,765,525 11.96
    2026-07-15 45,776,294 49,218,272 -3,441,978 9.75
    2026-06-30 49,218,272 50,318,535 -1,100,263 7.54
    2026-06-15 50,318,535 48,516,271 +1,802,264 7.46
    2026-05-29 48,516,271 51,849,425 -3,333,154 9.23
    2026-05-15 51,849,425 43,531,487 +8,317,938 7.68
    2026-04-30 43,531,487 38,812,013 +4,719,474 4.31
    2026-04-15 38,812,013 38,945,982 -133,969 15.42
    2026-03-31 38,945,982 39,439,406 -493,424 10.84
    2026-03-13 39,439,406 44,306,166 -4,866,760 7.66
    2026-02-27 44,306,166 45,259,873 -953,707 17.28
    2026-02-13 45,259,873 45,319,683 -59,810 11.92
    2026-01-30 45,319,683 42,557,725 +2,761,958 5.69
    2026-01-15 42,557,725 41,565,401 +992,324 7.53
    2025-12-31 41,565,401 40,578,361 +987,040 13.73
    2025-12-15 40,578,361 44,572,813 -3,994,452 10.40
    2025-11-28 44,572,813 40,235,935 +4,336,878 9.48
    2025-11-14 40,235,935 39,075,621 +1,160,314 4.13
    2025-10-31 39,075,621 30,904,192 +8,171,429 3.20

    Full FINRA short interest reporting calendar

    Showing 1–23 of 23 settlements
    Key facts CIK 1652130 CUSIP 45826J105 13F (30d) 38 filings 34 filers Visit website Investor relations